NCT02158000

Brief Summary

To notify the effect of aspiration of excessive endometrial fluid in addition to Diosmin in cases undergoing intracytoplasmic sperm injection (ICSI) cycles.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

June 5, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 6, 2014

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

June 28, 2022

Status Verified

June 1, 2022

Enrollment Period

7.4 years

First QC Date

June 5, 2014

Last Update Submit

June 24, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • the pregnancy rate

    is assessed by :serum hCG test Beta sub-unit of hCG (serum hCG test)

    is checked 16 days after embryos transfer

Secondary Outcomes (1)

  • presence of the fluid on the day of embryo transfer

    at the day of embryo transfer

Study Arms (2)

Group A

ACTIVE COMPARATOR

In group A , 100 women with excessive endometrial fluid by transvaginal ultrasound during ICSI cycles are allocated to receive one tab / 8 hs of Diosmin ( 500mg) beginning from the day of ovum retrieval and for 3 days (till the day of embro trasfer) in addition to aspiration of the fluid by an IUI catheter.

Other: group A

Group B

NO INTERVENTION

In group B (control group) 100 women with excessive endometrial fluid by transvaginal ultrasound during ICSI cycles, no thing will be done

Interventions

group AOTHER

one tab every 8 hs Diosmin ( 500mg) beginning from the day of ovum retrieval in addition to aspiration of the fluid by an IUI catheter

Also known as: Daflon
Group A

Eligibility Criteria

Age23 Years - 48 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • women with excessive endometrial fluid by transvaginal ultrasound during ICSI cycles

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benha univesity hospital

Banhā, El Qualyobia, 13518, Egypt

Location

Related Publications (1)

  • Saad AS, Mohamed KAA. Aspiration with Diosmin Intake in Endometrial Cavity Fluid Accumulation in ART Cycles: A Randomized Controlled Trial. J Obstet Gynaecol India. 2023 Aug;73(4):336-342. doi: 10.1007/s13224-023-01791-7. Epub 2023 Aug 31.

MeSH Terms

Conditions

Infertility

Interventions

Diosmin

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Intervention Hierarchy (Ancestors)

FlavonesFlavonoidsChromonesBenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • khalid mohamed

    Department of Obstetrics and Gynecology, Benha University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of ob/gyn

Study Record Dates

First Submitted

June 5, 2014

First Posted

June 6, 2014

Study Start

June 1, 2014

Primary Completion

November 1, 2021

Study Completion

November 1, 2021

Last Updated

June 28, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will share

on research gate

Locations